Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Ketamine is an NMDA receptor antagonist with psychotomimetic, dissociative, amnestic and euphoric effects. When chronically abused, ketamine users display deficits in cognition and information processing, even following long-term abstinence from the drug. While animal studies have shown evidence of behavioral changes and cognitive deficits that mimic those seen in humans within the period immediately following subchronic ketamine, a few animal studies have assessed long-term changes following cessation of ketamine exposure. To this end, the present study assessed event related potentials (ERPs) and EEG oscillations in mice exposed to subchronic ketamine following a 6month period of abstinence from the drug. Ketamine-treated mice showed no change in P20, but did show marked reductions in amplitude of the later N40 and P80 components, consistent with previous studies of acute ketamine exposure. Additionally, ketamine-treated animals showed a significant reduction in stimulus evoked theta oscillations. To assess the functional significance of these changes, mice were also assessed on a series of behavioral and cognitive tests, including progressive ratio (motivation), extinction (behavioral flexibility) and win-shift radial maze (spatial memory). Subchronic ketamine produced marked disruptions in reversal learning and spatial memory. Analysis of brains from ketamine-treated mice failed to show evidence of neuronal degeneration as determined by NueN immunohistochemistry, but did show increased astrocyte proliferation and decreased expression of the glial specific glutamate transporter, GLT-1. These results strongly suggest: 1) that subchronic ketamine induces significant changes in brain function that long exceed exposure to the drug; 2) that ketamine exposure in mice induces lasting cognitive impairments closely resembling those observed in human ketamine abusers; 3) that ERP and EEG measures are highly sensitive to alterations in brain function associated with reduced cognitive function; and 4) that the brain changes induced by chronic ketamine treatment are suggestive of long-term adaptive or plastic, rather than degenerative, changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remembrance of places passed: Spatial memory in rats.
Olton, D. S., & Samuelson, R. J. (1976) · Journal of Experimental Psychology: Animal Behavior Processes · doi:10.1037//0097-7403.2.2.97 · Cited by 1,998
Context, time, and memory retrieval in the interference paradigms of Pavlovian learning
Bouton, M. E. (1993) · Psychological Bulletin · doi:10.1037/0033-2909.114.1.80 · Cited by 1,896
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · cited 4×
“Neurotoxic damage has been reported in frontal cortex following ketamine exposure, and chronic ketamine administration can induce neurodegeneration in brain areas crucial for cognition (MajewskiTiedeken et al., 2008; Olney and Farber, 1995; Olney et al., 1989, 1999; Scallet et al., 2004; Wang et al., 2005; Young et al…”
BackgroundInfluentialNeural Mechanisms of Extinction Learning and Retrieval
Quirk, G. J., & Mueller, D. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301555 · Cited by 1,645
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
A triple dissociation of memory systems: Hippocampus, amygdala, and dorsal striatum.
McDonald, R. J., & White, N. M. (1993) · Behavioral Neuroscience · doi:10.1037/0735-7044.107.1.3 · Cited by 885
Kramis, R., Vanderwolf, C. H., & Bland, B. H. (1975) · Experimental Neurology · doi:10.1016/0014-4886(75)90195-8 · Cited by 791
Prefrontal mechanisms in extinction of conditioned fear
Quirk, G. J., Garcia, R., & González-Lima, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.010 · Cited by 682
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585
Human hippocampal theta oscillations and the formation of episodic memories
Lega, B. C., Jacobs, J., & Kahana, M. (2012) · Hippocampus · doi:10.1002/hipo.20937 · Cited by 485
Cited by
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
“Longer-term administration of ketamine to rats produced cognitive deficits similar to those observed in chronic schizophrenia (Featherstone et al., 2012).”
BackgroundAltered Cortical Ensembles in Mouse Models of Schizophrenia
Hamm, J. P., Peterka, D. S., Gogos, J. A., & Yuste, R. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.019 · Cited by 175
Wilkinson, S. T., Holtzheimer, P. E., Gao, S., Kirwin, D. S., & Price, R. B. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.004 · Cited by 95
“Notably, this is in contrast to the detrimental effects of long-term exposure to ketamine on cognition in rodent models (52) and high-frequency (HF) substance abusers (53).”
Sobota, R., Mihara, T., Forrest, A., Featherstone, R. E., & Siegel, S. J. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000074 · Cited by 80
“…(NMDA) receptor antagonist, can be used to induce changes in glutamatergic function in mouse models and produce social deficits and EEG changes similar to those seen in schizophrenia (Connolly et al., 2004; Ehrlichman et al., 2009; Featherstone et al., 2012; Kocsis, Brown, McCarley, & Hajos, 2013).”
MethodSelf-citationSmaga, I., Fierro, D., Mesa, J., Filip, M., & Knackstedt, L. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.016 · Cited by 69
“In adolescent male mice, chronic ketamine decreases GLT-1 and increases GFAP expression in the hippocampus, both of which are normalized by 14 days of 200 mg/kg ceftriaxone in C57BL/6Hsd mice (Dodman et al., 2015; Featherstone et al., 2012).”
BackgroundHydroxynorketamine Blocks N-Methyl-d-Aspartate Receptor Currents by Binding to Closed Receptors
Abbott, J. A., & Popescu, G. K. (2020) · Molecular Pharmacology · doi:10.1124/mol.120.119784 · Cited by 17
Metadata
- Authors
- Featherstone, R. E., Liang, Y., Saunders, J. A., Tatard-Leitman, V. M., Ehrlichman, R. S., & Siegel, S. J.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 47
- Issue
- 3
- Pages
- 338-346
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2000104590
- Cited by
- 74
- References
- 14
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.